Prodotto aggiunto correttamente al carrello.

discount label
H-VSNK-OH
Visualizzare in 3D

Biosynth logo

H-VSNK-OH

Rif. 3D-PP48115

1mg
172,00 €
10mg
196,00 €
100mg
303,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-VSNK-OH
Descrizione:

Peptide H-VSNK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VSNK-OH include the following: Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping YT Zhang, J Hu, AL Pace, R Wong, YJ Wang - of Chromatography B, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023214004127 Improving trastuzumab's stability profile by removing the two degradation hotspots Y Yang, J Zhao, S Geng, C Hou, X Li, X Lang - Journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354915300861 LC-MS Approach to Decipher a Light Chain Chromatographic Peak Splitting of a Monoclonal Antibody Y Liu , Z VanAernum , Y Zhang , X Gao, M Vlad - Pharmaceutical , 2023 - Springerhttps://link.springer.com/article/10.1007/s11095-023-03631-9 Characterization of IgG1 Fc deamidation at asparagine 325 and its impact on antibody-dependent cell-mediated cytotoxicity and FcγRIIIa binding X Lu, LA Machiesky, N De Mel, Q Du, W Xu - Scientific Reports, 2020 - nature.comhttps://www.nature.com/articles/s41598-019-57184-2 Analytical performance evaluation of identity, quality-attribute monitoring and new peak detection in a platform multi-attribute method using Lys-C digestion for X Li , NA Pierson , X Hua , BA Patel, MH Olma - Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354922004762 Qualification of Identity, Quality-Attribute Monitoring and New Peak Detection in An Improved Multi-Attribute Method with Lys-C Digestion for Characterization and X Li , NA Pierson , X Hua , BA Patel, MH Olma - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.05.01.490194.abstract Improvements on sample preparation and peptide separation for reduced peptide mapping based multi-attribute method analysis of therapeutic monoclonal X Li , B Rawal , S Rivera, S Letarte - of Chromatography A, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967322003545 Recent Applications of Quantitative Mass Spectrometry in Biopharmaceutical Process Development and Manufacturing X Li - Journal of Pharmaceutical and Biomedical Analysis, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708523003503 Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory T Pohl, A Gervais, EHC Dirksen, V D'Alessio - European Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0939641123001121 Utility of high resolution NMR methods to probe the impact of chemical modifications on higher order structure of monoclonal antibodies in relation to antigen binding S Majumder , A Saati, S Philip, LL Liu - Pharmaceutical , 2019 - Springerhttps://link.springer.com/article/10.1007/s11095-019-2652-1 High-resolution physicochemical characterization of different intravenous immunoglobulin products N Washburn, R Meccariello, S Hu , M Hains - Plos one, 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181251 Unusual fragmentation of derivatized cysteine-containing peptides N Degraan-Weber, B Zhao - Rapid Communications in , 2018 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.8196 Editorial and Review: 28th ASMS Sanibel Conference on Mass Spectrometry-Characterization of Protein Therapeutics by Mass Spectrometry JB Sperry , G Chen, JA Loo - Journal of The American Society for , 2017 - ACS Publicationshttps://pubs.acs.org/doi/full/10.1007/s13361-017-1629-8 Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature H Liu, G Gaza-Bulseco, J Sun - Journal of Chromatography B, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S157002320600287X Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control F Yang , J Zhang, A Buettner , E Vosika, M Sadek, Z Hao - MAbs, 2023 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2023.2197668 Forensic analysis of soman exposure using characteristic fragment ions from protein adducts F Fu, Y Guo, X Lu, P Zhao, S Zou - Human & , 2021 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/09603271211001111 Enzymatic removal of sialic acid enables iCIEF stability monitoring of charge variants of a highly sialylated bispecific antibody BH Peters , J Bautista, TR Slaney , H Guo - , 2022 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/elps.202100259 Coupling anion exchange chromatography with native mass spectrometry for charge heterogeneity characterization of monoclonal antibodies AP Liu , Y Yan , S Wang , N Li - Analytical chemistry, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.2c00707 Native Anion Exchange Chromatography Coupled to Mass Spectrometry for the Charge Variant Analysis of IgG4-Based Monoclonal Antibodies AM Rojahn, D Esser - 2024 - chromatographyonline.comhttps://www.chromatographyonline.com/view/native-anion-exchange-chromatography-coupled-mass-spectrometry-charge-variant-analysis-igg4-based-monoclonal-antibodies Asparagine deamidation dependence on buffer type, pH, and temperature AL Pace, RL Wong, YT Zhang, YH Kao - Journal of pharmaceutical , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002235491531073X Risk-based control strategies of recombinant monoclonal antibody charge variants A Beck , C Nowak, D Meshulam, K Reynolds, D Chen - Antibodies, 2022 - mdpi.comhttps://www.mdpi.com/2073-4468/11/4/73

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP48115 H-VSNK-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".